University of Pittsburgh Cancer Institute Cancer Services

Pittsburgh, Pennsylvania 15232-1305

1 studies enrolling now · 3 studies all time

What they study most

Ovarian Cancer, Prostate Cancer, Solid Tumors

Studies at this site

• Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
• Study of INCB123667 in Subjects With Advanced Solid Tumors — Running, not enrolling
• Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive — Completed